echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 6 best-selling anti-tumor varieties can be used by children in Hengrui, Hausen, and Yangtze River...the product has exploded

    6 best-selling anti-tumor varieties can be used by children in Hengrui, Hausen, and Yangtze River...the product has exploded

    • Last Update: 2021-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    On April 26, the CDE official website issued a notice that six anti-tumor varieties were selected after reviewing the list of varieties, which can be directly revised to increase the indications for children and the usage and dosage of the drug.


    We are now seeking opinions from the industry and the society.
    The 6 anti-tumor varieties are: cisplatin, ifosfamide, mesna, azathioprine, asparaginase and vindesine, involving Hengrui, Qilu, Shuanglu Pharmaceutical, Baiyunshan, Yangtze River, etc.


    Table 1: The specific situation of the revised opinions on adding children's medication information to the second batch of marketed drug inserts

    Source: CDE official website, compiled by Mi Nei.


    Table 2: The situation of the enterprises involved in the corresponding specifications of the 6 varieties

    Source: One-click search on Mi Nei.


    According to data from Meinenet, the above 6 anti-tumor drugs are all in the 2020 National Medical Insurance Catalogue, and domestic giants such as Hengrui, Qilu, Shuanglu Pharmaceutical, Baiyunshan, and Yangzijiang have layouts.


    In 2019, the sales scale of ifosfamide injection (including 0.


    Vindesine injection (1mg) has a terminal sales of 120 million yuan in public medical institutions in China in 2019.


    For a long time, my country's children's medicines have faced problems such as difficult research and development, fewer varieties of medicines, and lack of proprietary dosage forms.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.